Jan 23 (Reuters) - Ascentage Pharma ( ASPHF ) said on
Thursday it aims to raise $126.4 million in an initial public
offering in the U.S., becoming the first sizeable Chinese firm
to seek a listing in the United States this year.
(Reporting by Gursimran Kaur in Bengaluru; Editing by
Subhranshu Sahu)